REACT (Renal Autologous Cell Therapy)
GPTKB entity
Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:gene_therapy
|
| gptkbp:administeredBy |
injection into kidney
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:developedBy |
gptkb:ProKidney
|
| gptkbp:mechanismOfAction |
regeneration of kidney tissue
|
| gptkbp:routeOfAdministration |
intra-renal injection
|
| gptkbp:source |
patient's own kidney cells
|
| gptkbp:sponsor |
gptkb:ProKidney
|
| gptkbp:status |
gptkb:investigational_therapy
|
| gptkbp:targetAudience |
patients with type 2 diabetes and CKD
|
| gptkbp:usedFor |
chronic kidney disease
chronic kidney failure |
| gptkbp:bfsParent |
gptkb:ProKidney
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
REACT (Renal Autologous Cell Therapy)
|